Evidence map›Paper›PMID 26226446›Full record

Trial reportThe Pediatric infectious disease journal2015

The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children.

Humphrey Mulenga, Michele D Tameris, Kany Kany A Luabeya, Hennie Geldenhuys, Thomas J Scriba, Gregory D Hussey, Hassan Mahomed, Bernard S Landry, Willem A Hanekom, Helen McShane and 1 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Pediatric infectious disease journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00953927 (Phase II Double-blinded Randomized Controlled Evaluation of MVA85A/AERAS-485 for Safety, Immunogenicity and Prevention of Tuberculosis in BCG-vaccinated, HIV-negative Infants), which is not on this map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00953927 phase2completednot on this map

Phase II Double-blinded Randomized Controlled Evaluation of MVA85A/AERAS-485 for Safety, Immunogenicity and Prevention of Tuberculosis in BCG-vaccinated, HIV-negative Infants

TypeinterventionalSponsorAerasRan2009Enrolled2,797ConditionsTuberculosisArmsMVA85A/AERAS-485, Candida Skin Test Antigen
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. MVA85A vaccine to enhance BCG for preventing tuberculosis.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Childhood tuberculosis in Vienna between 2010 and 2016.Wiener klinische Wochenschrift · 2019
    Article
  10. Quality of care in childhood tuberculosis diagnosis at primary care clinics in Kampala, Uganda.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Article
  11. Surgical release for tubercular elbow stiffness.Infection and drug resistance · 2018
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Humphrey MulengaFrom the *South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine (IDM), Department of Pediatrics & Child Health, University of Cape Town; †Vaccines for Africa (VACFA), Institute of Infectious Disease & Molecular Medicine, University of Cape Town; ‡Division of Community Health, Stellenbosch University and Western Cape Government: Health, Cape Town, South Africa; §Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; and ¶Aeras, Rockville, Maryland.
Michele D Tameris
Kany Kany A Luabeya
Hennie Geldenhuys
Thomas J Scriba
Gregory D Hussey
Hassan Mahomed
Bernard S Landry
Willem A Hanekom
Helen McShane
Mark Hatherill
University of Cape Town · ZASouth African Tuberculosis Vaccine Initiative · ZAAeras · USJenner Institute · GBWestern Cape Department of Health · ZA

Funding

Wellcome Trust 076943Wellcome Trust 095780
6 · The paper itself

Abstract

backgroundChildhood tuberculosis (TB) is usually Mycobacterium tuberculosis (MTB) culture negative. Furthermore, clinical presentation may be altered by active case finding, isoniazid prophylaxis and early treatment. We aimed to establish the value of presenting symptoms for intrathoracic TB case diagnosis among young children.

methodsHealthy, HIV-uninfected, South African infants in an efficacy trial of a novel TB vaccine (MVA85A) were followed for 2 years for suspected TB. When suspected, investigation followed a standardized algorithm comprising symptom history, QuantiFERON Gold-in-Tube, chest radiography (CXR), MTB culture and Xpert MTB/RIF from paired gastric lavage and induced sputa. Adjusted odds ratios and 95% confidence intervals describe the associations between symptoms and positive MTB culture or Xpert MTB/RIF, and CXR compatible with intrathoracic TB.

resultsPersistent cough was present in 172/1017 (16.9%) of the children investigated for TB. MTB culture/Xpert MTB/RIF was positive in 38/1017 children (3.7%); and CXR was positive, that is, compatible with intrathoracic TB, in 131/1017 children (12.9%). Children with persistent cough had more than triple the odds of a positive MTB culture/Xpert MTB/RIF (adjusted odds ratios: 3.3, 95% confidence interval: 1.5-7.0) and positive CXR (adjusted odds ratios: 3.5, 95% confidence interval: 2.2-5.5). Persistent cough was the only symptom that differentiated children with severe (56.5%) from nonsevere intrathoracic TB disease (28.2%; P = 0.001).

conclusionPersistent cough was the cardinal diagnostic symptom associated with microbiologic and radiologic evidence, and disease severity, of intrathoracic TB. Symptom-based definitions of TB disease for diagnostic, preventive and therapeutic studies should prioritize persistent cough above other symptoms compatible with childhood TB.

Indexed as

Mycobacterium tuberculosisChild, PreschoolFemaleHumansInfantMalePredictive Value of TestsTuberculosis, Pulmonary

Identifiers

PMID26226446
PMCPMC4604651
OpenAlexW2395297645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.